Sulfadiazine Sodium Injection
Market– Regional Analysis
On the basis of region, the
global Sulfadiazine
Sodium Injection Market is segmented into North America, Latin America,
Europe, Asia Pacific, Middle East, and Africa.
North America is estimated to
hold the leading position in sulfadiazine sodium injection market due to rising
use of antibiotics. For instance, according to the U.S. Food and Drug
Administration (USFDA) 2015, about 9.7 million kilograms (21.4 million pounds)
of antibiotics considered important for human use were sold for use in animal
agriculture.
Europe is also expected to
witness significant growth in the global sulfadiazine sodium injection market,
owing to rising awareness of antibiotics resistance and safe and effective
practice of antibiotics use in the region. For instance, the European
Antibiotic Awareness Day is celebrated on 18 November every year. On November
16, 2018, the symposium for the 11th European Antibiotic Awareness Day was
hosted by the Federal Ministry for Labour, Social Affairs, Health and Consumer
Protection in cooperation with the Austrian national reference centre. The
agenda for the symposium focused on raising awareness about importance of
prudent antibiotic use.
* The sample copy includes: Report
Summary, Table of Contents, Segmentation, Competitive Landscape, Report
Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2313
Sulfadiazine sodium is one of the
short acting sulfonamide used in combinations with pyrimethamine. It is used in
treating toxoplasmosis in patients with acquired immunodeficiency syndrome and
in newborns with congenital infections. It is used for prevention of recurrent
attacks of rheumatic fever, urinary tract infections, and chlamydial infections
in humans. Sulfadiazine sodium injections are also used in veterinary animals
such as cattles to manage respiratory tract infections, genitourinary
infections, alimentary tract infections, and sepsis.
Sulfadiazine Sodium Injection
Market– Drivers
Rising awareness for safe
antibiotic uses due to widespread antibiotic resistance can drive high demand
for sulfadiazine sodium injection in the global market during the forecast
period. For instance, World Antibiotic Awareness Week (WAAW) observed every
year in the month of November, purposes to increase global awareness of
antibiotic resistance (AMR) and encourage best practices among public, health
workers, and policy makers to avoid emergence and spread of antibiotic
resistance.
Furthermore, the mission of
Alliance for the Prudent Use of Antibiotics (APUA) started in 1981, is working
to strengthen global defenses against infectious diseases by ensuring access to
effective antibiotics treatment and promoting appropriate antibiotic use to
reduce drug resistance. By 2018, APUA is working in 19 countries and stands as
the world’s leading organization conducting research and education on antimicrobial
treatment and resistance at the grassroots and global levels.
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/sulfadiazine-sodium-injection-market-2313
Sulfadiazine Sodium Injection
Market– Restraint
Over the years, bacterial
pathogens acquired resistance to sulfonamide class of antibiotics, due to
mutations in pre-existing DNA, or by acquisition of antibiotic resistance genes
(ARGs), which is expected to hinder growth of the sulfachloropyridazine sodium
market. For instance, according to Centers for Disease Control and Prevention
(CDC), in the U.S. doctors and emergency departments, prescribe at least 47 million
antibiotic prescriptions each year, which are unnecessary. These are creating
spread of antibiotics resistance, which might lead to severe consequences.
Sulfadiazine Sodium Injection
Market– Competitive Analysis
Key players operating in the
global sulfadiazine sodium injection market include, AdvaCare Pharma, Mercator
Pharma, Shijiazhuang ZDHF Stock-Raising Co., Ltd, Pegasus Laboratories, Inc.,
Weifang Fubang Pharmaceutical Co., Ltd., Hebei Tianyuan Pharmaceutical Co.,
Ltd., Hebei Veyong Animal Pharmaceutical Co., Ltd., and GENERA d.d.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2313
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment